Non-Small Cell Lung Cancer Brain Metastasis (MSK, Nat Commun 2023)

Summary

Non-Small Cell Lung Cancer Brain Metastasis (MSK, Nat Commun 2023) is a study catalogued by cBioPortal DataHub under the cancer-type code nsclc. EvidenceHelix groups it with lung and pleura studies.

Study description

Targeted sequencing of 322 NSCLC brain metastasis and their matched normals via MSK-IMPACT.

Text as published in the source's study metadata.

Citation & PubMed

Anna et al. Nat Commun 2023

Linked PubMed records: PMID 37591896

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

bm_nsclc_mskcc_2023

Short name

not given

Source cancer-type code

nsclc

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Anna et al. Nat Commun 2023

• PubMed record 37591896 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Metastatic Non-Small Cell Lung Cancer (MSK, Nature Medicine 2022)

  Targeted sequencing of ctDNA samples drawn from patients with metastatic NSCLC using the Resolution ctDx Lung platform. For more information contact jeej@mskcc.org or lib1@mskcc.org

  Lung and pleuraMSK studiesSource code nsclcPubMed 1

• Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)

  Whole-exome sequencing of 75 tumor/normal NSCLC pairs treated with PD-1 plus CTLA-4 blockade..

  Lung and pleuraMSK studiesSource code nsclcPubMed 1

• Non-Small Cell Lung Cancer (MSK, J Clin Oncol 2018)

  IMPACT sequencing of 240 NSCLC tumor/normal pairs treated at MSKCC with anti-PD-(L)1 based therapy.

  Lung and pleuraMSK studiesSource code nsclcPubMed 1

• Non-Small Cell Lung Cancer (MSK, Science 2015)

  Whole exome sequencing of tumor-normal tissue pairs from 16 non-small cell lung cancer samples.

  Lung and pleuraMSK studiesSource code nsclcPubMed 1

• Non-Small Cell Lung Cancer (TRACERx, NEJM & Nature 2017)

  Whole-exome sequencing of 327 primary tumors with matched germline samples, and phylogenetic ctDNA sequencing of 96 pre- and 24 postoperative samples from 100 NSCLC TRACERx patients.

  Lung and pleuraOther published and consortium studiesSource code nsclcPubMed 2

• Non-Small Cell Lung Cancer (University of Turin, Lung Cancer 2017)

  Targeted next-generation sequencing of 41 NSCLC samples.

  Lung and pleuraOther published and consortium studiesSource code nsclcPubMed 1

• Pan-Lung Cancer (TCGA, Nat Genet 2016)

  Whole-exome sequencing of 660 lung ADC and 484 lung SqCC tumor/normal pairs.

  Lung and pleuraTCGA (other releases)Source code nsclcPubMed 1

• Atypical Small Cell Lung Cancer (MSK, Cancer Discov 2024)

  Targeted sequencing of 31 atypical small cell lung cancers lacking RB1 and TP53 co-inactivation and their matched normals via MSK-IMPACT, including structural variant analysis via whole-genome sequencing. This data is…

  Lung and pleuraMSK studiesSource code lungPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.